Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 10/20 | 0.66 |
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | RECQL | P46063 | 2/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | APEX1 | P27695 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.66 |
| ▸ | GPR18 | Q14330 | 1/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL231559 | 0.93 | FAAH (0.74) | FAAHMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL342264 | 0.91 | FAAH (0.77) | FAAHMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL22076706 | 0.91 | FAAH (0.77) | FAAHMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL125481 | 0.91 | FAAH (0.77) | FAAHMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL343546 | 0.91 | FAAH (0.77) | FAAHMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL23619536 | 0.91 | FAAH (0.77) | FAAHMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL2032732 | 0.91 | FAAH (0.77) | FAAHMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL20544019 | 0.91 | FAAH (0.77) | FAAHMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL2926148 | 0.91 | FAAH (0.77) | FAAHMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL9860572 | 0.91 | FAAH (0.77) | FAAHMEN1KMT2AALDH1A1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100273-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | claimed |
| US-20220175851-A1 | COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-06-09 | — | — | US | claimed |
| US-20220118269-A1 | MONITORING EFFICACY OF MAGNETIC AND ELECTRIC FIELDS USING BIOMARKERS | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2022-04-21 | — | — | US | claimed |
| US-20210088539-A1 | AUTOMATED SAMPLE QUALITY ASSESSMENT | METABOLON, INC. | 2021-03-25 | — | — | US | claimed |
| US-10890592-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2021-01-12 | — | — | US | claimed |
| WO-2020186161-A2 | COMPOSITIONS AND METHODS FOR REGULATING UTERINE AND PLACENTAL GROWTH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-09-17 | — | — | WO | claimed |
| CN-107014934-A | Urine organic acid filter paper quality-control product and preparation method thereof | 广州金域医学检验中心有限公司 | 2017-08-04 | — | — | CN | claimed |
| CN-101142167-A | Compounds that stimulate glucose utilization and methods of use | UNIV ALBERTA (CA) | 2008-03-12 | — | — | CN | claimed |
| US-5112863-A | N-Acyl Amino Acid Derivative | NIPPON OIL & FATS CO., LTD. (JP) | 1992-05-12 | — | — | US | claimed |
| EP-0432039-A2 | Antipsychotic drug comprising an acylaminoacid | NIPPON OILS & FATS CO., LTD. (JP) | 1991-06-12 | — | — | EP | claimed |
| EP-0130644-B1 | USE OF 2-PENTANOYLAMINOACETIC ACID AND SALTS THEREOF | CONTINENTAL PHARMA, INC. (BE) | 1988-11-02 | — | — | EP | claimed |
| US-4562205-A | ANTIEPILEPTIC AGENT, ANTIDE RESSANTS, COGNITION ACTIVATORS, AND TREATMENT OF PARKINSON'S DISEASE | CONTINENTAL PHARMA INC. (BE) | 1985-12-31 | — | — | US | claimed |
| EP-0130644-A1 | Use of 2-Pentanoylaminoacetic acid and salts thereof | CONTINENTAL PHARMA, INC. (BE) | 1985-01-09 | — | — | EP | claimed |
| WO-2026100273-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20260036547-A1 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | ASTRAZENECA AB (SE) | 2026-02-05 | — | — | US | disclosed |
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | UNIV CALIFORNIA (US) | 2025-12-11 | — | — | US | disclosed |
| EP-0130644-A1 | Use of 2-Pentanoylaminoacetic acid and salts thereof | CONTINENTAL PHARMA, INC. (BE) | 1985-01-09 | — | — | EP | disclosed |
| EP-0130644-A1 | Use of 2-Pentanoylaminoacetic acid and salts thereof | CONTINENTAL PHARMA, INC. (BE) | 1985-01-09 | — | — | EP | disclosed |
| EP-0130644-A1 | Use of 2-Pentanoylaminoacetic acid and salts thereof | CONTINENTAL PHARMA, INC. (BE) | 1985-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375505-A1 | COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM | CYP27A1, LIPC, CYP46A1 | FAAH 1529/4885MEN1 2550/4885KMT2A 3068/4885 |
| US-20260036547-A1 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | ATP5ME, ATP5MF, ATP5MK | FAAH 598/4885MEN1 3305/4885KMT2A 4225/4885 |
| US-20220175851-A1 | COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH | PGF, FGR, VEGFA | FAAH 1065/4885MEN1 4274/4885KMT2A 3937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.